Dopamine D3 receptor antagonists as therapeutic agents

This publication has 76 references indexed in Scilit:

• Association between dopamine D3 receptor gene polymorphisms and schizophrenia in an isolate population
  Schizophrenia Research, 2005
• Lack of functional D2 receptors prevents the effects of the D3-preferring agonist (+)-PD 128907 on dialysate dopamine levels
  Neuropharmacology, 2005
• Clozapine‐, but not haloperidol‐, induced increases in ΔFosB‐like immunoreactivity are completely blocked in the striatum of mice lacking D3 dopamine receptors
  European Journal of Neuroscience, 2004
• Phenotypic analysis of dopamine receptor knockout mice; recent insights into the functional specificity of dopamine receptor subtypes
  Neuropharmacology, 2004
• Hypofrontality in schizophrenia: a meta‐analysis of functional imaging studies
  Acta Psychiatrica Scandinavica, 2004
• Selective blockade of D3 dopamine receptors enhances the anti-parkinsonian properties of ropinirole and levodopa in the MPTP-lesioned primate
  Experimental Neurology, 2004
• Myopathy Related to Administration of a Cationic Amphiphilic Drug and the Use of Multidose Drug Distribution Analysis to Predict its Occurrence
  Toxicologic Pathology, 2004
• Methamphetamine‐induced loss of striatal dopamine innervation in BDNF heterozygote mice does not further reduce D₃ receptor concentrations
  Synapse, 2004
• Selective Antagonism at Dopamine D3 Receptors Enhances Monoaminergic and Cholinergic Neurotransmission in the Rat Anterior Cingulate Cortex
  Neuropsychopharmacology, 2002
• D1 Agonist Dihydrexidine Releases Acetylcholine and Improves Cognitive Performance in Rats
  Pharmacology Biochemistry and Behavior, 1997